StonvexLoading…
StonvexStonvexStonvexCore line items from OTEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $5.17B | $5.77B | $4.48B | $3.49B |
Operating Income | $892.69M | $887.09M | $516.29M | $644.77M |
Net Income | $435.87M | $465.09M | $150.38M | $397.09M |
EPS (Diluted) | $1.65 | $1.71 | $0.56 | $1.46 |
Total Assets | $13.77B | $14.21B | $17.09B | $10.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.16B | $1.28B | $1.23B | $1.69B |
Free Cash Flow OCF − CapEx | $687.40M | $808.40M | $655.37M | $888.70M |
Shares Outstanding | 254.78M | 267.80M | 270.90M | 269.52M |